Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RAS ONCOGENES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 177 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. DiPaola, RS; Patel, J; Rafi, MM
      Targeting apoptosis in prostate cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    2. Cheung, WC; Van Ness, B
      The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro

      LEUKEMIA
    3. Mason, KA; Komaki, R; Cox, JD; Milas, L
      Biology-based combined-modality radiotherapy: Workshop report

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    4. Brown, JM
      Therapeutic targets in radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    5. Walentinsson, A; Levan, G
      Ras gene mutations in 7,1 2-dimethylbenz[alpha]anthracene (DMBA)-induced rat sarcomas

      CANCER LETTERS
    6. Ewis, AA; Kondo, K; Lee, J; Tsuyughuchi, M; Hashimoto, M; Yokose, T; Mukai, K; Kodama, T; Shinka, T; Monden, Y; Nakahori, Y
      Occupational cancer genetics: Infrequent ras oncogenes point mutations in lung cancer samples from chromate workers

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    7. Gupta, AK; Bakanauskas, VJ; McKenna, WG; Bernhard, EJ; Muschel, RJ
      Ras regulation of radioresistance in cell culture

      REGULATORS AND EFFECTORS OF SMALL GTPASES, PT G
    8. Arboleda, MJ; Eberwein, D; Hibner, B; Lyons, JF
      Dominant negative mutants of mitogen-activated protein kinase pathway

      REGULATORS AND EFFECTORS OF SMALL GTPASES, PT F, RAS FAMILY I
    9. Topham, MK; Prescott, SM
      Diacylglycerol kinase zeta regulates Ras activation by a novel mechanism

      JOURNAL OF CELL BIOLOGY
    10. Hu, BC; Zhou, XY; Wang, X; Zeng, ZC; Iliakis, G; Wang, Y
      The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Whitehall, WLJ; Walsh, MD; Young, J; Leggett, BA; Jass, JR
      Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability

      CANCER RESEARCH
    12. de Molina, AR; Rodriguez-Gonzalez, A; Penalva, V; Lucas, L; Lacal, JC
      Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    13. Vecchio, G; Santoro, M
      Oncogenes and thyroid cancer

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    14. Ayene, IS; Bernhard, EJ; McKenna, WG; Muschel, RJ; Krisch, RE; Koch, CJ
      DNA as an important target in radiation-induced apoptosis of MYC and MTC plus RAS transfected rat embryo fibroblasts

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    15. O'Gorman, DM; McKenna, SL; McGahon, AJ; Knox, KA; Cotter, TG
      Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals

      LEUKEMIA
    16. Suarez, HG
      Molecular basis of epithelial thyroid tumorigenesis

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    17. Guan, J; DiBiase, S; Iliakis, G
      The catalytic subunit DNA-dependent protein kinase (DNA-PKcs) facilitates recovery from radiation-induced inhibition of DNA replication

      NUCLEIC ACIDS RESEARCH
    18. Belka, C; Knippers, P; Rudner, J; Faltin, H; Bamberg, M; Budach, W
      MEK1 and Erk1/2 kinases as targets for the modulation of radiation responses

      ANTICANCER RESEARCH
    19. Lantry, LE; Zhang, ZQ; Crist, KA; Wang, Y; Hara, M; Zeeck, A; Lubet, RA; You, M
      Chemopreventive efficacy of promising farnesyltransferase inhibitors

      EXPERIMENTAL LUNG RESEARCH
    20. Ivanov, AV; Kopnin, PB; Kondratov, RV; Osovskaya, VS; Kopnin, BP; Chumakov, PM
      A p53 mutation is required for stable transformation of REF52 cells by themyc and ras oncogenes

      MOLECULAR BIOLOGY
    21. Lahr, G
      RT-PCR from archival single cells is a suitable method to analyze specificgene expression

      LABORATORY INVESTIGATION
    22. Ding, H; Wu, XL; Roncari, L; Lau, N; Shannon, P; Nagy, A; Guha, A
      Expression and regulation of neuropilin-1 in human astrocytomas

      INTERNATIONAL JOURNAL OF CANCER
    23. Are, AF; Galkin, VE; Pospelova, TV; Pinaev, GP
      The p65/RelA subunit of NF-kappa B interacts with actin-containing structures

      EXPERIMENTAL CELL RESEARCH
    24. Calabuig, PSF; Lucas, DJ; Esteva, OB; Guirado, AG; Cubero, JCP
      Colorectal carcinoma: inductor circumstances (etiology) and pathogenic ways (pathogenesis)

      REVISTA CLINICA ESPANOLA
    25. Bristol, JA; Orsini, C; Lindinger, P; Thalhamer, J; Abrams, SI
      Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization

      CELLULAR IMMUNOLOGY
    26. Maity, A; Pore, N; Lee, J; Solomon, D; O'Rourke, DM
      Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3 '-kinase and distinct from that inducedby hypoxia

      CANCER RESEARCH
    27. Warenius, HM; Jones, M; Gorman, T; McLeish, R; Seabra, L; Barraclough, R; Rudland, P
      Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity

      BRITISH JOURNAL OF CANCER
    28. Rizos, E; Sourvinos, G; Arvanitis, DA; Velegrakis, G; Spandidos, DA
      Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours

      ORAL ONCOLOGY
    29. Norgaard, P; Law, B; Joseph, H; Page, DL; Shyr, Y; Mays, D; Pietenpol, JA; Kohl, NE; Oliff, A; Coffey, RJ; Poulsen, HS; Moses, HL
      Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis

      CLINICAL CANCER RESEARCH
    30. Saetta, A; Lazaris, AC; Tseleni-Balafouta, S; Davaris, PS
      Prevalence and clinicopathologic associations of ras mutations in gastrointestinal neoplasms

      GI CANCER
    31. Russo, D; Arturi, F; Pontecorvi, A; Filetti, S
      Genetic analysis in fine-needle aspiration of the thyroid: A new tool for the clinic

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    32. Zhang, M; Endo, Y; Sasaki, T
      Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2 '-deoxy-1-beta-D-arabinofuranosylcytosine

      INTERNATIONAL JOURNAL OF ONCOLOGY
    33. Tchernitsa, OI; Zuber, J; Sers, C; Brinckmann, R; Britsch, SK; Adams, V; Schafer, R
      Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators

      ONCOGENE
    34. Weis, B; Giehl, K; Gana-Weisz, M; Egozi, Y; Ben-Baruch, G; Marciano, D; Gierschik, P; Kloog, Y
      A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice

      ONCOGENE
    35. Kamada, N
      Biological dosimetry of atomic bomb survivors exposed within 500 meters from the hypocenter and the health consequences

      JOURNAL OF RADIATION RESEARCH
    36. Tsukamoto, A; Kaneko, Y; Yoshida, T; Ichinose, M; Kimura, S
      Regulation of angiogenesis in human hepatomas: possible involvement of p53-inducible inhibitor of vascular endothelial cell proliferation

      CANCER LETTERS
    37. Dokianakis, DN; Varras, MN; Papaefthimiou, M; Apostolopoulou, J; Simiakaki, H; Diakomanolis, E; Spandidos, DA
      Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids

      CLINICAL & EXPERIMENTAL METASTASIS
    38. de Castro, IP; Malumbres, M; Santos, J; Pellicer, A; Fernandez-Piqueras, J
      Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas

      CARCINOGENESIS
    39. Xie, B; Tsao, SW; Wong, YC
      Induction of high incidence of mammary tumour in female Noble rats with a combination of 17 beta-oestradiol and testosterone

      CARCINOGENESIS
    40. Muto, S; Yokoi, T; Gondo, Y; Katsuki, M; Shioyama, Y; Fujita, K; Kamataki, T
      Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice

      CARCINOGENESIS
    41. Pospelov, VA; Pospelova, TV; Svetlikova, SB; Kukushkin, AN; van der Eb, A
      Changes in the transcription factor AP-1 composition in rat embryo fibroblasts transformed with E1A+Ha-Ras oncogenes

      MOLECULAR BIOLOGY
    42. Verheijen, MHG; Wolthuis, RMF; Bos, JL; Defize, LHK
      The Ras/Erk pathway induces primitive endoderm but prevents parietal endoderm differentiation of F9 embryonal carcinoma cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    43. Wynford-Thomas, D
      Molecular basis of tumours arising from the thyroid follicular cell.

      ANNALES DE CHIRURGIE
    44. Gomori, E; Doczi, T; Pajor, L; Matolcsy, A
      Sporadic p53 mutations and absence of ras mutations in glioblastomas

      ACTA NEUROCHIRURGICA
    45. SCHUTZE K; LAHR G
      IDENTIFICATION OF EXPRESSED GENES BY LASER-MEDIATED MANIPULATION OF SINGLE CELLS

      Nature biotechnology
    46. IWAYA T; MAESAWA C; NISHIZUKA S; SUZUKI Y; SAKATA K; SATO N; IKEDA K; KOEDA K; OGASAWARA S; OTSUKA K; KIMURA Y; AOKI K; ISHIDA K; SAITO K; TAMURA G
      INFREQUENT FRAMESHIFT MUTATIONS OF POLYNUCLEOTIDE REPEATS IN MULTIPLEPRIMARY CANCERS AFFECTING THE ESOPHAGUS AND OTHER ORGANS

      Genes chromosomes & cancer (Print)
    47. LI BL; MURPHY KL; LAUCIRICA R; KITTRELL F; MEDINA D; ROSEN JM
      A TRANSGENIC MOUSE MODEL FOR MAMMARY CARCINOGENESIS

      Oncogene
    48. LIN AW; BARRADAS M; STONE JC; VANAELST L; SERRANO M; LOWE SW
      PREMATURE SENESCENCE INVOLVING P53 AND P16 IS ACTIVATED IN RESPONSE TO CONSTITUTIVE MEK MAPK MITOGENIC SIGNALING/

      Genes & development
    49. REBISCHUNG C; LAURENTPUIG P; GERARD JP; THOMAS G; HAMELIN R
      ANALYSIS OF GENETIC ALTERATIONS IN RECTAL-CANCER - DIFFERENCES AS COMPARED WITH COLON-CANCER

      Gastroenterologie clinique et biologique
    50. INIESTA P; DEJUAN C; CALDES T; VEGA FJ; MASSA MJ; CERDAN FJ; LOPEZ JA; FERNANDEZ C; SANCHEZ A; TORRES AJ; BALIBREA JL; BENITO M
      GENETIC ABNORMALITIES AND MICROSATELLITE INSTABILITY IN COLORECTAL-CANCER

      Cancer detection and prevention
    51. LUTTGES J; VOGEL I; MENKE M; HENNEBRUNS D; KREMER B; KLOPPEL G
      CLEAR-CELL CARCINOMA OF THE PANCREAS - AN ADENOCARCINOMA WITH DUCTAL PHENOTYPE

      Histopathology
    52. LALL L; DAVIDSON RL
      SEQUENCE-DIRECTED BASE MISPAIRING IN HUMAN ONCOGENES

      Molecular and cellular biology
    53. ELALL HA; REY A; DUVILLARD P
      EXPRESSION OF HEAT-SHOCK-PROTEIN-70 AND C-MYC IN CERVICAL-CARCINOMA

      Anticancer research
    54. GOLUBIC M; HARWALKAR JA; BRYANT SS; SUNDARAM V; JOVE R; LEE JH
      DIFFERENTIAL REGULATION OF NEUROFIBROMIN AND P120 GTPASE-ACTIVATING PROTEIN BY NUTRITIONALLY RELEVANT FATTY-ACIDS

      Nutrition and cancer
    55. WANG Y; PERRAULT AR; ILIAKIS G
      REPLICATION PROTEIN-A AS A POTENTIAL REGULATOR OF DNA-REPLICATION IN CELLS EXPOSED TO HYPERTHERMIA

      Radiation research
    56. ANDREW SE; MCKINNON M; CHENG BS; FRANCIS A; PENNEY J; REITMAIR AH; MAK TW; JIRIK FR
      TISSUES OF MSH2-DEFICIENT MICE DEMONSTRATE HYPERMUTABILITY ON EXPOSURE TO A DNA METHYLATING AGENT

      Proceedings of the National Academy of Sciences of the United Statesof America
    57. BULAVIN DV; KURASH YK; AKSENOV ND; POSPELOV VA; POSPELOVA TV
      THE EFFECT OF DNA-DAMAGING AGENTS ON THE P53 PRB-DEPENDENT PATHWAY INRAT EMBRYO FIBROBLASTS TRANSFORMED WITH E1A+HA-RAS ONCOGENES/

      Molecular biology
    58. KURASH YK; ROZANOV YM; BULAVIN DV; POSPELOV VA; POSPELOVA TV
      CELL-CYCLE STRUCTURE AND APOPTOSIS OF E1AAD5-IMMORTALIZED RAT-CELLS UPON EXPOSURE TO DNA-DAMAGING AGENTS

      Molecular biology
    59. ELLIS LM; STALEY CA; LIU WB; FLEMING RYD; PARIKH NU; BUCANA CD; GALLICK GE
      DOWN-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN A HUMAN COLON-CARCINOMA CELL-LINE TRANSFECTED WITH AN ANTISENSE EXPRESSION VECTOR SPECIFIC FOR C-SRC

      The Journal of biological chemistry
    60. BERGMANNLEITNER ES; KANTOR JA; SHUPERT WL; SCHLOM J; ABRAMS SI
      IDENTIFICATION OF A HUMAN CD8(-LYMPHOCYTE NEO-EPITOPE CREATED BY A RAS CODON-12 MUTATION WHICH IS RESTRICTED BY THE HLA-A2 ALLELE() T)

      Cellular immunology (Print)
    61. WARENIUS HM; JONES M; JONES MD; BROWNING PG; SEABRA LA; THOMPSON CCM
      LATE G(1) ACCUMULATION AFTER 2 GY OF GAMMA-IRRADIATION IS RELATED TO ENDOGENOUS RAF-1 PROTEIN EXPRESSION AND INTRINSIC RADIOSENSITIVITY IN HUMAN-CELLS

      British Journal of Cancer
    62. GREIPP PR; LEONG T; BENNETT JM; GAILLARD JP; KLEIN B; STEWART JA; OKEN MM; KAY NE; VANNESS B; KYLE RA
      PLASMABLASTIC MORPHOLOGY - AN INDEPENDENT PROGNOSTIC FACTOR WITH CLINICAL AND LABORATORY CORRELATES - EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) MYELOMA TRIAL E9486 REPORT BY THE ECOG MYELOMA LABORATORY GROUP

      Blood
    63. WADLER S; BAJAJ R; NEUBERG D; AGARWAL V; HAYNES H; BENSON AB
      PROGNOSTIC IMPLICATIONS OF C-KI-RAS2 MUTATIONS IN PATIENTS WITH ADVANCED COLORECTAL-CANCER TREATED WITH 5-FLUOROURACIL AND INTERFERON - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (EST-2292)

      The cancer journal from Scientific American
    64. RAPTIS L; YANG JT; BROWNELL H; LAI J; PRESTON T; CORBLEY MJ; NARSIMHAN RP; HALIOTIS T
      RAS(LEU61) BLOCKS DIFFERENTIATION OF TRANSFORMABLE 3T3 L1 AND C3H10T 1 2-DERIVED PREADIPOCYTES IN A DOSE-DEPENDENT AND TIME-DEPENDENT MANNER/

      Cell growth & differentiation
    65. WIRNSBERGER GH; KLEINERT R; LANGMANN G; FUCHS U
      TUMOR-CELL MARKERS IN UVEAL MELANOMA - AN IMMUNOHISTOCHEMICAL STUDY

      International journal of oncology
    66. SAYLE TXT; GOODFELLOW JM
      SEQUENCE-DEPENDENT ALKYLATION OF GUANINE RESIDUES IN DUPLEX DNA - MOLECULAR-DYNAMICS STUDY

      Journal of the Chemical Society. Faraday transactions
    67. BOCCADORO M; PILERI A
      DIAGNOSIS, PROGNOSIS, AND STANDARD TREATMENT OF MULTIPLE-MYELOMA

      Hematology/oncology clinics of North America
    68. PINSET C; GARCIA A; ROUSSE S; DUBOIS C; MONTARRAS D
      WORTMANNIN INHIBITS IGF-DEPENDENT DIFFERENTIATION IN THE MOUSE MYOGENIC CELL-LINE C2

      Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie
    69. MICHAELI J; CHOY CG; ZHANG XJ
      THE BIOLOGICAL FEATURES OF MULTIPLE-MYELOMA

      Cancer investigation
    70. LANTRY LE; ZHANG ZQ; GAO F; CRIST KA; WANG Y; KELLOFF GJ; LUBET RA; YOU M
      CHEMOPREVENTIVE EFFECT OF PERILLYL ALCOHOL ON 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE INDUCED TUMORIGENESIS IN (C3H HEJ-X-A/J)F-1 MOUSE LUNG/

      Journal of cellular biochemistry
    71. BOIGE V; LAURENTPUIG P
      GENETIC ALTERATIONS IN HEPATOCELLULAR-CAR CINOMA

      Gastroenterologie clinique et biologique
    72. GIBBS JB; OLIFF A
      THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS

      Annual review of pharmacology and toxicology
    73. WANG Y; CHEONG N; MIURA M; ILIAKIS G
      OVEREXPRESSION OF INSULIN-LIKE-GROWTH-FACTOR (IGF)-I RECEPTOR ENHANCES INHIBITION OF DNA-REPLICATION IN MOUSE CELLS EXPOSED TO X-RAYS

      Radiation and environmental biophysics
    74. MCCARTHY SA; CHEN D; YANG BS; RAMIREZ JJG; CHERWINSKI H; CHEN XR; KLAGSBRUN M; HAUSER CA; OSTROWSKI MC; MCMAHON M
      RAPID PHOSPHORYLATION OF ETS-2 ACCOMPANIES MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION AND THE INDUCTION OF HEPARIN-BINDING EPIDERMAL GROWTH-FACTOR GENE-EXPRESSION BY ONCOGENIC RAF-1

      Molecular and cellular biology
    75. PROVIAS J; CLAFFEY K; DELAGUILA L; LAU N; FELDKAMP M; GUHA A
      MENINGIOMAS - ROLE OF VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR IN ANGIOGENESIS AND PERITUMORAL EDEMA

      Neurosurgery
    76. MIRZAYANS R; ENNS L; PATERSON MC
      INHIBITION OF DNA-SYNTHESIS AND G(1) S-PHASE TRANSITION IN NORMAL HUMAN FIBROBLASTS ELICITED BY A HEAT-LABILE TRANS-ACTING FACTOR IN GAMMA-IRRADIATED HELA-CELL EXTRACTS/

      Radiation research
    77. YAMAMOTO S; HAYASHI Y; MITSUMORI K; NOMURA T
      RAPID CARCINOGENICITY TESTING SYSTEM WITH TRANSGENIC MICE HARBORING HUMAN PROTOTYPE C-HRAS GENE

      Laboratory animal science
    78. PAL S; CLAFFEY KP; DVORAK HF; MUKHOPADHYAY D
      THE VON-HIPPEL-LINDAU GENE-PRODUCT INHIBITS VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN RENAL-CELL CARCINOMA BY BLOCKING PROTEIN-KINASE-C PATHWAYS

      The Journal of biological chemistry
    79. DIAMANDIS EP
      CLINICAL-APPLICATIONS OF TUMOR-SUPPRESSOR GENES AND ONCOGENES IN CANCER

      Clinica chimica acta
    80. WANG Y; PERRAULT AR; ILIAKIS G
      DOWN-REGULATION OF DNA-REPLICATION IN EXTRACTS OF CAMPTOTHECIN-TREATED CELLS - ACTIVATION OF AN S-PHASE CHECKPOINT

      Cancer research
    81. THOMPSON HJ; JIANG C; LU JX; MEHTA RG; PIAZZA GA; PARANKA NS; PAMUKCU R; AHNEN DJ
      SULFONE METABOLITE OF SULINDAC INHIBITS MAMMARY CARCINOGENESIS

      Cancer research
    82. RICHELDA R; RONCHETTI D; BALDINI L; CRO L; VIGGIANO L; MARZELLA R; ROCCHI M; OTSUKI T; LOMBARDI L; MAIOLO AT; NERI A
      A NOVEL CHROMOSOMAL TRANSLOCATION T(4-14)(P16.3-Q32) IN MULTIPLE-MYELOMA INVOLVES THE FIBROBLAST GROWTH-FACTOR RECEPTOR-3 GENE

      Blood
    83. CONTASTA I; PELLEGRINI P; BERGHELLA AM; DELBEATO T; CANOSSI A; DIROCCO M; ADORNO D; CASCIANI CU
      NECESSITY OF BIOTHERAPEUTIC TREATMENTS INDUCING TH1 CELL FUNCTIONS INCOLORECTAL-CANCER

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    84. HECHT SS
      RECENT STUDIES ON MECHANISMS OF BIOACTIVATION AND DETOXIFICATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK), A TOBACCO-SPECIFIC LUNG CARCINOGEN

      Critical reviews in toxicology
    85. CLARK HM; YANO T; SANDER C; JAFFE ES; RAFFELD M
      MUTATION OF THE RAS GENES IS A RARE GENETIC EVENT IN THE HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA

      Leukemia
    86. MIHARA K; IIJIMA M; KONDO T; NAMBA M
      SELECTIVE EXPRESSION OF MUTATED P53 IN HUMAN-CELLS IMMORTALIZED WITH EITHER 4-NITROQUINOLINE 1-OXIDE OR CO-60 GAMMA-RAYS

      Cell structure and function
    87. OGAWA K; TOKUSASHI Y; FUKUDA I
      ABSENCE OF P53 MUTATIONS IN METHYLNITROSOUREA-INDUCED MAMMARY-TUMORS IN RATS

      Cancer detection and prevention
    88. DEVRIES JE; TENKATE J; BOSMAN FT
      P21(RAS) IN CARCINOGENESIS

      Pathology research and practice
    89. VAGELI D; KIARIS H; DELAKAS D; ANEZINIS P; CRANIDIS A; SPANDIDOS DA
      TRANSCRIPTIONAL ACTIVATION OF H-RAS, K-RAS AND N-RAS PROTOONCOGENES IN HUMAN BLADDER-TUMORS

      Cancer letters
    90. PAGES JC; SORDAT B; BAUTISTA D; COSTA J; BENHATTAR J
      DETECTION OF RARE CIRCULATING HUMAN COLON-TUMOR CELLS IN A NUDE-MOUSEXENOGRAFT MODEL

      Cancer letters
    91. WULFFBARREIRO E
      THE NATURAL-HISTORY OF THE DISCOVERY OF H EREDITARY CARCINOGENESIS OFTHE COLON - SCIENTIFIC DYNAMICS IN INFORMATION-FLOW

      Arbor
    92. KONDO T; MIHARA K; INOUE Y; NAMBA M
      2-DIMENSIONAL ELECTROPHORETIC STUDIES ON DOWN-REGULATED INTRACELLULARTRANSFERRIN IN HUMAN FIBROBLASTS IMMORTALIZED BY TREATMENT WITH EITHER 4-NITROQUINOLINE 1-OXIDE OR CO-60 GAMMA-RAYS

      Electrophoresis
    93. CHENG XB; CHEONG N; WANG Y; ILIAKIS G
      IONIZING RADIATION-INDUCED PHOSPHORYLATION OF RPA P34 IS DEFICIENT INATAXIA-TELANGIECTASIA AND REDUCED IN AGED NORMAL FIBROBLASTS

      Radiotherapy and oncology
    94. CLARKE R
      ANIMAL-MODELS OF BREAST-CANCER - THEIR DIVERSITY AND ROLE IN BIOMEDICAL-RESEARCH

      Breast cancer research and treatment
    95. KRANTZ CK; ROUTES BA; QUINLAN MP; COOK JL
      E1A 2ND EXON REQUIREMENTS FOR INDUCTION OF TARGET-CELL SUSCEPTIBILITYTO LYSIS BY NATURAL-KILLER-CELLS - IMPLICATIONS FOR THE MECHANISM OF ACTION

      Virology
    96. WANG Y; HUG MS; ILIAKIS G
      EVIDENCE FOR ACTIVITIES INHIBITING IN TRANS INITIATION OF DNA-REPLICATION IN EXTRACT PREPARED FROM IRRADIATED-CELLS

      Radiation research
    97. JIANG HP; SU ZZ; LIN JJ; GOLDSTEIN NI; YOUNG CSH; FISHER PB
      THE MELANOMA DIFFERENTIATION-ASSOCIATED GENE MDA-7 SUPPRESSES CANCER CELL-GROWTH

      Proceedings of the National Academy of Sciences of the United Statesof America
    98. POSPELOV VA; POSPELOVA TV
      CHARACTERIZATION OF THE SRF DNA-BINDING ACTIVITY IN CELLS TRANSFORMEDWITH ONCOGENE HA-RAS

      Molecular biology
    99. POSPELOVA TV; KUKUSHKIN AN; MEDVEDEV AV; SAVELEV AK; POSPELOV VA
      ACTIVITY AND COMPOSITION OF TRANSCRIPTION FACTOR AP-1 IN RAT EMBRYO FIBROBLASTS TRANSFORMED WITH ONCOGENES E1A AND HA-RAS

      Molecular biology
    100. OHTA Y; KIJIMA H; KASHANISABET M; SCANLON KJ
      SUPPRESSION OF THE MALIGNANT PHENOTYPE OF MELANOMA-CELLS BY ANTIONCOGENE RIBOZYMES

      Journal of investigative dermatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 00:43:02